{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles all mention \"Lockdown\" but the passages are either empty or just \"Lockdown\" again. The only meaningful part is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe that's a typo or a fragment.\n\nFirst, I need to define a lockdown based on general knowledge since the context isn't very helpful. A lockdown is typically a strict set of measures imposed by authorities to restrict movement and gatherings to control the spread of a disease, like during a pandemic. But the user might be expecting an answer that uses the context provided. However, the context here is incomplete. The passage mentions \"non-lockdown\" and \"implemented with lockdown\" but doesn't give a clear definition. \n\nWait, the user might be testing if I can infer from the given context. The context titles suggest that the study is about the impact of lockdowns versus non-lockdown measures. The passage fragment \"banned Implemented with lockdown.57 24/3/2020\" could be a date or a reference code. Maybe \"57\" is a percentage or a number related to the study. But without more info, I can't use that to define lockdown. \n\nSo, the safest approach is to answer based on general knowledge but note that the context provided is insufficient. The user might want a concise answer. Let me check if there's any standard definition. A lockdown usually involves restricting people's movement, closing non-essential businesses, schools, and public places to prevent the spread of infectious diseases. It's a public health measure. \n\nSince the context doesn't provide a clear definition, I should answer based on common understanding but mention that the context is limited. Alternatively, maybe the user expects me to use the context even if it's minimal. The titles mention estimating infections and the impact of non-lockdown, so perhaps the study compared lockdowns to no lockdowns. But the answer should still define what a lockdown is. \n\nI think the best way is to provide the standard definition and note that the context is not sufficient for a detailed answer. That way, the user gets the correct information and knows the context wasn't helpful. Let me structure the answer accordingly.\n</think>\n\nA **lockdown** is a public",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which is the Chikungunya virus. I need to look through the provided context to find all the mentioned complications.\n\nFirst, the first passage lists several complications from most common to least. Let me check that again. It says: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. So those are the main ones mentioned there.\n\nThen, looking at the second part of the passage, there's mention of neonates. It says that mothers can transmit CHIKV during the perinatal period, leading to high morbidity. The neonates showed symptoms by day 4, and six had meningoencephalitis. Also, another part mentions nineteen cases of neonatal infection leading to encephalitis due to vertical transmission. So encephalitis is a complication here, specifically in neonates.\n\nWait, the first passage already listed meningoencephalitis as a complication. So in the neonatal cases, they mention encephalitis again. Are these the same? Meningoencephalitis is inflammation of the brain and meninges, while encephalitis is just the brain. But in the context, they might be considered under central nervous system problems. However, the user wants all complications mentioned, so I should include both meningoencephalitis and encephalitis as separate points if they are mentioned in different contexts.\n\nAlso, the passage mentions \"other central nervous system problems,\" so maybe encephalitis is part of that. But since it's specifically called out in the neonatal cases, it's better to list it. Let me make sure I don't miss any.\n\nSo compiling all the complications:\n\nFrom the first part:\n- Respiratory failure\n- Cardiovascular decompensation\n- Meningoencephalitis\n- Severe acute hepatitis\n- Severe cutaneous effects\n- Other central nervous system problems\n- Kidney failure\n\nFrom the neonatal part:\n- Encephalitis (specifically in neonates due to vertical transmission)\n- High morbidity in neonates (though that's more about the outcome than a complication, but maybe it's part of the complications)\n\nWait, the question is about complications associated with CHIKV. So the answer",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Passage: and complications.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers .",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the passages, I notice mentions of clades like 1B.1, 1B.2, 1C.2, 1A.1, and 1A.1.1. However, there's no direct mention of \"Clade A\" in the given text. The titles and passages refer to different lineages such as 1B human seasonal, 1C swine lineage, and their subdivisions.\n\nThe first passage talks about exceptions in clades 1B.1 and 1B.2. The second passage mentions exceptions for 1A.1 and 1A.1.1. The third passage discusses the 1C lineage. The term \"Clade A\" isn't used here. It's possible that the user might be referring to a clade labeled as \"A\" in the original study, but based on the provided context, there's no information about Clade A. The answer would need to state that there's no information provided about Clade A in the given context. Alternatively, maybe there's a misinterpretation, and the user meant one of the existing clades like 1A.1 or 1C.2, but without more data, the correct response is that the context doesn't mention Clade A.\n</think>\n\nThe provided context does not mention or describe \"Clade A.\" The text references clades such as **1B.1**, **1B.2**, **1C.2**, **1A.1**, and **1A.1.1**, but there is no information about a clade explicitly labeled \"Clade A.\" If the question refers to a clade designated as \"A\" in the original study, this detail is absent from the given context. \n\n**Answer:** The context does not provide information about Clade A.",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 ."
      ],
      "computed_relevance": 0.8,
      "computed_utilization": 0.8,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. Also, it notes that the core domain of the RBD (receptor binding domain) is highly conserved. \n\nWait, the context starts by saying that most bat SARS-related CoVs have two deletions in the spike receptor binding domain compared to human SARS-CoV. But then it contrasts 2019-nCoV with those bat viruses. The S1 subunit's identity is 70%, which is lower than the S2's 99% identity. The RBD core is conserved, though. \n\nSo the answer should mention the 70% identity for S1 and note the conserved RBD core. Also, maybe mention that unlike most bat CoVs, 2019-nCoV doesn't have those deletions in the RBD? Wait, the first sentence says that most bat SARSr-CoVs have deletions in the RBD compared to human SARS-CoV. But the 2019-nCoV's RBD is conserved. So maybe that's why the S1 has higher similarity here. \n\nThe user's question is specifically about the S1 subunit comparison. The answer should state the 70% identity and the conserved RBD core. Also, maybe note that in the context of the S1 subunit, which includes the RBD, the deletions present in other bat CoVs aren't there in 2019-nCoV, making it more similar to human SARS-CoV. \n\nI need to make sure I don't confuse S1 and S2. The S2 is highly conserved (99%), while S1 is 70%. The RBD is part of S1. So the answer should clarify that while the overall S1 is 70% identical, the RBD core is conserved. That's an important distinction because the RBD is crucial for binding to the host receptor. \n\nPutting it all",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from two passages.\n\nFirst, I need to look through the given context. The first passage mentions that Bacillus species, including subtilis, are found in traditional fermented foods and are used in probiotics like Biosubtyl, Biosporin, etc. It also says they're used in food industry as starter cultures. The second passage talks about how Bacillus subtilis was not considered part of the normal intestinal microbiome but is now recognized for its benefits. It produces surfactins, fengycins, and iturins in specific ratios. It helps restore gut microflora balance by increasing beneficial bacteria and decreasing harmful ones. Also, it maintains gut barrier integrity, reduces endotoxins, and inflammation.\n\nSo, putting this together, Bacillus subtilis is a species of Bacillus that's used as a probiotic. It's found in fermented foods and commercial probiotics. Its role is to support gut health by balancing the microbiome and reducing inflammation. The answer should mention its classification, use in probiotics, production of compounds, and its effects on gut health. Need to make sure not to include any other species unless necessary. Also, check if there's any specific details like the ratio of compounds (6:37:57) but maybe that's too detailed. The key points are the probiotic use, gut health benefits, and the specific mechanisms like producing surfactins, etc.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus, historically recognized for its presence in traditional fermented foods and its use as a probiotic. It is employed in commercial probiotic products (e.g., Biosubtyl, Biosporin) to support intestinal health. Unlike some Lactobacillus species, it was not initially classified as part of the normal intestinal microbiome but is now understood to confer benefits such as restoring gut microbiota balance by increasing beneficial bacteria (e.g., Bifidobacterium, Lactobacillus) and reducing harmful species (e.g., Clostridium). It also produces bioactive compounds like surfactins, fengycins, and iturins, which help maintain gut barrier integrity, reduce inflammation, and lower endotoxin levels.",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp.",
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) ."
      ],
      "computed_relevance": 0.5555555555555556,
      "computed_utilization": 0.8888888888888888,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves, but the user is interested in single-wave pandemics. However, there's a mention of the 1918 pandemic's herald waves possibly stretching back to 1915. The 1918 pandemic itself is known for having multiple waves, so maybe not directly relevant here. Still, the context talks about viruses circulating before the recognized pandemic, which might relate to how pandemics start but not specifically about single-wave ones.\n\nNext, the second context is about the 2009 H1N1 pandemic in Hong Kong. It discusses research on epidemiology, impact, and control, considering five gradations of pandemic severity and various interventions. However, the 2009 pandemic had multiple waves in some regions, so maybe not a single-wave example. The study here is more about response strategies rather than the pandemic's wave structure.\n\nThe third context from Taiwan discusses the 2009 pH1N1 pandemic and uses a Richards model variation to analyze multiple waves. They mention distinguishing between two types of turning points in multi-wave epidemics. This seems to focus on multi-wave scenarios, so not directly answering the question about single-wave.\n\nThe fourth context is an economic analysis of mitigation strategies for five pandemic severity categories. It references studies using individual-based models and costing models. The focus here is on economic strategies and interventions across different severity levels, not specifically on single-wave pandemics.\n\nPutting this together, the contexts provided don't explicitly mention research on severe, single-wave pandemics. They discuss multi-wave pandemics (like 1889, 1918, 2009) and studies related to their epidemiology, control measures, and economic impacts. The user's question is about severe, single-wave pandemics, which isn't directly addressed in the given contexts. However, there's a mention of the 1889 pandemic having three waves, but the 1892 wave was the most intense. Maybe that's considered a single severe wave in some analyses? But the context still refers to multiple waves overall.\n\nAlternatively, the 1918 pandemic's",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.5,
      "computed_completeness": 0.5,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the given context. The user is asking for the number of reported viral pneumonia cases, so I need to look through each of the provided passages to find any mention of numbers related to viral pneumonia.\n\nFirst, looking at the first passage: it's about pneumonia in adults hospitalized with influenza in the US from 2005-2008. It mentions that patients with pneumonia were more likely to receive antiviral therapy. But there's no specific number given here about the total cases of viral pneumonia. It's more about the treatment differences between those with and without pneumonia.\n\nNext, the second passage is a clinical review on primary influenza viral pneumonia. It talks about bacterial co-infections in the 2009 H1N1 pandemic, mentioning 77 fatal cases where 29% had bacterial pneumonia. However, this is about co-infection rates, not the total number of viral pneumonia cases. So this might not be the number we're looking for.\n\nThird passage is about the 2019-nCoV (now known as COVID-19) guideline. Here, it states that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection. This seems like a direct mention of viral pneumonia cases caused by the novel coronavirus. The question is about \"reported viral pneumonia,\" and this is a specific number. But I need to check if there are other numbers in the context.\n\nThe fourth passage again from the same clinical review on influenza mentions attack rates during pandemics, like the 2009 H1N1 example. It gives percentages but not actual numbers. The last part of the context says \"A total of 51 cases have been cured and discharged...\" but this seems to be part of the same passage as the 2744 number, possibly referring to the same 2019-nCoV cases. The 51 cured might be part of that 2744 total. However, the question is about reported viral pneumonia, so the key number here is 2744 confirmed cases of pneumonia with 2019-nCoV.\n\nLooking back at the other passages, the first one is about influenza and pneumonia in the US, but no specific total numbers. The",
      "retrieved_chunks": [
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.1111111111111111,
      "computed_utilization": 0.1111111111111111,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage mentions genetic recombination studies but doesn't talk about the primary method. The third passage discusses genome analyses and specific regions like the spike protein, but again, the method isn't mentioned there. The fourth passage emphasizes vigilance and data sharing but not the analysis method. \n\nSo the first passage clearly states that high throughput or deep sequencing is the main method. The answer should be that most analysis has been done using high throughput (deep) sequencing methods for complete genome deduction. I need to present this concisely, using the exact terms from the context.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach was highlighted as the primary tool for studying MERS-CoV's genetic variations and global spread.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "The technique can produce genomic ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. Let me look through the provided context and passages to find the relevant information.\n\nFirst, the context mentions that images were produced showing GFP-expressing cells in white and non-GFP cells in black. That's probably part of the tracking method. Then, in the first passage, they talk about generating single-cell clones with GFP using puromycin selection. But how does that relate to tracking spread?\n\nLooking at the second passage from the title \"Accelerated viral dynamics...\" it says that after applying the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were seen. That seems like a direct method of tracking. They used a microscope to observe when cells started expressing GFP, which would indicate infection spread.\n\nAnother part mentions MLV particles being concentrated, but that's about preparation, not tracking. The key here is the use of fluorescence microscopy to monitor GFP expression over time. Since GFP is a reporter here, the spread would be visualized by observing the increase in GFP-positive cells under the microscope. The images with white cells (GFP+) and black (non-GFP) probably helped in quantifying the spread by counting the number of infected cells over time.\n\nSo putting it all together, the method involved using fluorescence microscopy to periodically check the cells for GFP expression, allowing them to track how the infection spread as more cells became GFP-positive. The answer should mention the inverted fluorescence microscope and monitoring over time.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked by **monitoring plates periodically using an inverted fluorescence microscope** to observe the first signs of GFP expression. This allowed the authors to visualize and quantify the progression of infection over time, as GFP-expressing cells appeared white in the images, while non-infected cells remained black. This method enabled real-time tracking of viral spread through fluorescence detection. \n\n**Answer:** The spread was tracked using periodic monitoring with an inverted fluorescence microscope to observe GFP expression.",
      "retrieved_chunks": [
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator ."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.8,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention emergency management related to COVID-19. The passages talk about noncontaminated CT disinfection procedures after examining a suspected case, fever-CT disinfection after examination, and preparing to disinfect imaging equipment immediately after.\n\nThe key points here are that after an examination involving a suspected or confirmed COVID-19 case, the CT scanner needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"fever-CTs\" might refer to CT scanners used specifically for patients with fever, which is a common symptom of COVID-19. \n\nThe answer should probably include steps like using appropriate disinfectants, following sterilization protocols, and ensuring that the equipment is properly cleaned to prevent cross-contamination. Since the context mentions \"noncontaminated CT disinfection procedures,\" maybe there's a specific method or sequence they follow. However, the exact steps aren't detailed in the provided passages, so the answer might be more general. \n\nI should make sure to highlight that the procedure involves immediate disinfection after the exam, using proper equipment and sterilization methods. The answer should be concise, based on the given context, without adding external information. The user might be looking for confirmation that immediate disinfection is required, and that specific protocols are in place for CT scanners in such cases.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment** following the examination of a suspected or confirmed case. This includes adhering to established sterilization protocols, such as using appropriate disinfectants and ensuring thorough cleaning of all surfaces and components of the CT scanner to prevent cross-contamination. The process emphasizes prompt action post-examination to mitigate the risk of viral transmission.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}